Top

Supportive Care in Cancer

Published in:

01-02-2014 | Original Article

Prevalence of anxiety and depression and their risk factors in Chinese cancer patients

Authors: Jin Sheng Hong, Jun Tian

Published in: Supportive Care in Cancer | Issue 2/2014

Abstract

Purpose

This paper aimed to obtain information on the levels of anxiety and depression among cancer patients in China. The factors influencing these psychological problems were also analyzed.

Methods

A total of 1,217 cancer patients were interviewed, and each participant was asked to complete a self-administered questionnaire. The anxiety status, depression status, disease stage, tumor site, pain status, and performance status of the patients during the week prior to the interview were assessed.

Results

The anxiety and depression prevalence rates were 6.49 and 66.72 %, respectively. The prevalence rates of depression were 60.62 % for head and neck cancer, 77.19 % for lung cancer, 57.9 % for breast cancer, 75.81 % for esophagus cancer, 63.40 % for stomach cancer, 68.42 % for liver cancer, 54.37 % for colorectal cancer, and 71.13 % for cervix cancer. The factors influencing depression of patients were performance status (P < 0.0001), pain (P = 0.0003), age (P < 0.0001), and education level (P < 0.0001). The risk factors of anxiety were performance status (P = 0.0007), age (P < 0.0001), and gender (P < 0.0001).

Conclusions

Depression was a more important psychological problem than anxiety in cancer patients. Compared with 3.8 % of the prevalence of depression in normal population, depression level was high among Chinese cancer patients. Patients with lung, esophagus, and cervix cancers were the high-risk groups for depression. Poor performance status, pain, old age, and low-level education were the predicting factors for depression.

Zhang YN, Zhang HW, Song LL, Tang LL (2010) Application of the NCCN Distress Thermometer in Chinese cancer patients. Chin Ment Health 24(12):897–901

Al-Shakhli H, Harcourt D, Kenealy J (2006) Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic. J Plast Reconstr Aesthet Surg 59:479–486. doi:10.1016/j.bjps.2005.01.010 PubMedCrossRef

Montazeri A, Milroy R, Hole D et al (1998) Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health 52:203–204PubMedCrossRef

Penelope H, Richard J (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18(4):893–903

Stoudemire A, Thompson TL (1983) Medication non-compliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatry 5:233–239PubMedCrossRef

Tian J, Chen ZC, Hang LF (2009) The effects of psychological status of the patients with digestive system cancers on prognosis of the disease. Cancer Nurs 32(3):230–235PubMedCrossRef

Gramignano G, Lusso MR, Madeddu C et al (2006) Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 2:136–145CrossRef

Van CE, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 2:S51–S63

Greer S (1983) Cancer and the mind. Br J Psychiatry 143:535–543PubMedCrossRef

10.

Miller AH (1998) Neuroendocrine and immune system interactions in stress and depression. Psychiatr Clin N Am 21:454–456CrossRef

11.

Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57–71PubMedCrossRef

12.

Chapman CR (1979) Psychological and behavioral aspects of cancer pain. Adv Pain Res Ther 2:45–56

13.

Takahashi T, Hondo M, Nishimura K et al (2008) Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy. Radiat Med 26:39–401CrossRef

14.

So WK, Marsh G, Ling WM et al (2009) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 14:17–22. doi:10.1016/j.ejon. 2009.07.005 PubMedCrossRef

15.

Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28PubMedCrossRef

16.

Strong V, Waters R, Hibberd C, Rush R, Cargill A, Storey D, Walker J, Wall L, Fallon M, Sharpe M (2007) Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study. Br J Cancer 96:868–874. doi:10.1038/sj.bjc.6603626 PubMedCentralPubMedCrossRef

17.

Pascoe S, Edelman S, Kidman A (2000) Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. J Psychiatry 34:785–791

18.

Ashraff S, Gupta SLA, Chaudhury LCS et al (2004) Effect of short-term psychiatric intervention in cancer patients. MJAFI 60:109–112

19.

Korfage IJ, Essink-Bot ML, Janssens AC, Schröder FH, Koning HJ (2006) Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94:1093–1098PubMedCentralPubMedCrossRef

20.

Tagay S, Herpertz S, Langkafel M et al (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Care Rehab 15:695–703

21.

Chen ML, Zhang HK, Yeh CH (2000) Anxiety and depression in Taiwanese cancer patients with and without pain. J Adv Nurs 32:944–951PubMed

22.

Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psych Oncol 10(1):19–28CrossRef

23.

Medeiros M, Oshima CT, Forones NM (2010) Depression and anxiety in colorectal cancer patients. J Gastrointest Cancer 41(3):179–184PubMedCrossRef

24.

Evans DL, McCartney CF, Nemeroff CB, Raft D, Quade D, Golden RN et al (1986) Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry 143:447–451PubMed

25.

Mashhadi MA, Mansoor S, Zahra Z (2013) Evaluation of depression in patients with cancer in South of Iran (Zahedan). Iran J Cancer Prev 6:112–116

26.

Vukojević M, Perić I, Kordić M (2012) Anxiety and depression in oncology patients in the Mostar University Clinical Hospital. Lijec Vjesn 134(7–8):208–214PubMed

27.

Tel H, Sari A, Aydin HT (2013) Social support and depression among the cancer patients. Glob J Med Res K: Interdiscip 13(3) Version 1.0 (online ISSN: 2249–4618)

28.

Laird BJ, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psychooncology 18(5):459–464PubMedCrossRef

29.

Jack L, Scott A, Colvin L, Laird B, Fallon M (2011) Pain and depression in cancer patients: a longitudinal study. BMJ Support Palliat Care 1:A11. doi:10.1136/bmjspcare-2011-000020.30 CrossRef

30.

Jehn CF, Flath B, Strux A, Krebs M, Possinger K, Pezzutto A, Lüftner D (2012) Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer. Breast Cancer Res Treat 136(3):789–794PubMedCrossRef

31.

Lin CC, Lai YL (2003) Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. J Pain Symptom Manag 25(1):29–37CrossRef

32.

Lansky SB, List MA, Hermann CA (1985) Absence of major depressive disorder in female cancer patients. J Clin Oncol 3:1553–1560PubMed

33.

Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105(12):1814–1817. doi:10.1038/bjc.2011.503 PubMedCentralPubMedCrossRef

34.

Lueboonthavatchai P (2007) Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thail 90(10):2164–2174

35.

Wang XD, Wang XL, Ma H (1999) Rating scales for mental health. Zhongguo Xingli Weisheng Zazhi, Beijing

36.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

37.

Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1990) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J Psychsom 40(4):29–34

38.

Gao LP, Weng CS (2008) Influencing factors of quality of life in cancer patients of initial stages receiving radio- and chemotherapy and its countermeasures. Nurs J Chin People's Liberation Army 8:10–12

39.

Spijker AV, Trijsberg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293

40.

Zang YJ, Zao Z, Meng JX (2004) The clinical analysis for anxiety and depression of hypertension patients. Med J Chin People Health 116(111):675–676

41.

Cancer Institute of China (2001) The incidences and mortalities of malignant tumors in some regions of China, vol 1. China Medical Technology, Beijing, pp 1–39

42.

Liu Y, Wang YF, Shong LQ et al (2007) The progress in the study on depression of cancer patients. Chin J of Beh Med Sci l16(11):1054–1056

43.

Wan CH, Luo JH, Yang Z, Meng Q (2007) Measurements and applications of quality of life in patients with cancers. Kexue, Beijing

44.

Fernandes WC, Kimura M (2010) Health related quality of life of women with cervical cancer. Rev Latino-Am Enfermagem 18(3):360–367CrossRef

45.

Burns M, Costello J, Ryan-Woolley B, Davidson S (2007) Assessing the impact of late treatment effects in cervical cancer: an exploratory study of women's sexuality. Eur J Cancer Care 16:364–372CrossRef

46.

Wei RC (2010) The sex life and its influencing factors in cervical cancer patients after surgery. Chin J Nurs 45(9):843–844

47.

Chen X, Lu W, Zheng Y et al (2010) Exercise, tea consumption, and depression among breast cancer survivors. J Clin Oncol 28:991–998PubMedCrossRef

48.

Grav S, Hellzèn O, Romild U, Stordal E (2012) Association between social support and depression in the general population: the HUNT study, a cross-sectional survey. J Clin Nurs 21(1–2):111–120PubMedCrossRef

49.

Mohr DC, Classen C, Barrera M Jr (2004) The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 34(3):533–541PubMedCrossRef

Title: Prevalence of anxiety and depression and their risk factors in Chinese cancer patients
Authors: Jin Sheng Hong
Jun Tian
Publication date: 01-02-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 2/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-013-1997-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children

Effects of telemonitoring in cancer patients

Mental health-care utilization in survivors of childhood cancer and siblings: the Swiss childhood cancer survivor study

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study

Citation analysis of Canadian psycho-oncology and supportive care researchers

Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies

Keynote webinar | Spotlight on antibody–drug conjugates in cancer